Distinct functions of endogenous cannabinoid system in alcohol abuse disorders.
Balapal S BasavarajappaVikram JoshiMadhu ShivakumarShivakumar SubbannaPublished in: British journal of pharmacology (2019)
Δ9 -tetrahydrocannabinol, the principal active component in Cannabis sativa extracts such as marijuana, participates in cell signalling by binding to cannabinoid CB1 and CB2 receptors on the cell surface. The CB1 receptors are present in both inhibitory and excitatory presynaptic terminals and the CB2 receptors are found in neuronal subpopulations in addition to microglial cells and astrocytes and are present in both presynaptic and postsynaptic terminals. Subsequent to the discovery of the endocannabinoid (eCB) system, studies have suggested that alcohol alters the eCB system and that this system plays a major role in the motivation to abuse alcohol. Preclinical studies have provided evidence that chronic alcohol consumption modulates eCBs and expression of CB1 receptors in brain addiction circuits. In addition, studies have further established the distinct function of the eCB system in the development of fetal alcohol spectrum disorders. This review provides a recent and comprehensive assessment of the literature related to the function of the eCB system in alcohol abuse disorders.
Keyphrases
- alcohol consumption
- cell surface
- systematic review
- induced apoptosis
- small molecule
- poor prognosis
- inflammatory response
- single cell
- high throughput
- multiple sclerosis
- resting state
- spinal cord injury
- oxidative stress
- neuropathic pain
- spinal cord
- cell death
- endoplasmic reticulum stress
- binding protein
- clinical evaluation